Royalty Pharma

Business briefs: Healthcare reform, J&J, Lilly, Quest

The healthcare reform information campaign continues; J&J settles a shareholder lawsuit; Eli Lilly freezes company salaries; and Quest dumps cancer med royalty rights.

Business Briefs: inVentiv; Mylan; Royalty Pharma; Pfizer; Edelman

inVentiv adds new comms exec; Julie Bowen teams up with Mylan for allergy emergencies; Royalty raises the bid on Elan; Pfizer nixes non-Hodgkin's lymphoma drug in trials.

Email Newsletters